CapsuleTech is partnering with Masimo (NSDQ:MASI) on its latest SmartLinx patient-monitoring system, company officials said.

CapsuleTech’s new SmartLinx Vitals Plus Patient Monitoring System will utilize Masimo's SET Measure-through Motion and Low Perfusion technology, which monitors oxygen levels in the blood, and CapsuleTech's SmartLinx Neuron 2 mobile clinical computer. The latest system will enable caregivers to monitor patient oxygenation levels, pulse rates and perfusion indexes.

In addition to monitoring vital signs, the new system will also be able to deliver that data to hospital electronic records systems and 3rd-party mobile devices.

The companies added that Masimo's technology has been shown to reduce the number of oximetry-related "false alarms" by more than 95% and increase "true alarm" detection by over 97%.

"The integration of Masimo SET with SmartLinx Vitals Plus will provide caregivers the ability to more accurately measure a patients' oxygenation, even during challenging conditions of patient motion and low perfusion," said CapsuleTech CEO Gene Cattarina, in a release. "With Vitals Plus, we have a product in a class of its own with its clinician-friendly workflow and cost-effective design that enables hospitals to move from charting to monitoring all with the same Neuron 2."

In February, Masimo reported double-digit growth in sales and solid gains in net income during the final quarter of 2014.